SOUTH SAN FRANCISCO, Calif., March 18, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced the publication of abstracts for ...
Questions may be submitted (via chat function) during the live webinar or submitted in advance via email to investors@xenon-pharma.com. Click to enlarge A live webcast of the webinar will be available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results